Novel fusion protein PK5-RL-Gal-3C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity

Xiaoge Gao(Xuzhou Medical College), Qing Zhang(South China University of Technology)

BMC Cancer

February 15, 2023

10.1186/s12885-023-10608-9

Cited by 3

Related Papers

Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models

|Journal of Immunology Research|2018|152

HAb18G/CD147 Functions in Invasion and Metastasis of Hepatocellular Carcinoma

|Molecular Cancer Research|2007|148

Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway

|Oncotarget|2014|65

A novel galactose-PEG-conjugated biodegradable copolymer is an efficient gene delivery vector for immunotherapy of hepatocellular carcinoma

|Biomaterials|2018|57

Down-regulation of caveolin-1 in mouse Lewis lung cancer P29 is a causal factor for the malignant properties in a high-metastatic subline

|Oncology Reports|2006|4